Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

BACKGROUND: Allogeneic hematopoietic cell transplantation (alloHCT) for multiple myeloma (MM), with its underlying graft-versus-tumor capacity, is a potentially curative approach for high-risk patients. Relapse is the main cause of treatment failure, but predictors for post-relapse survival are not...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biol Blood Marrow Transplant
Asıl Yazarlar: Gomez-Arteaga, Alexandra, Shah, Gunjan L., Baser, Raymond E, Scordo, Michael, Ruiz, Josel D., Bryant, Adam, Dahi, Parastoo B., Ghosh, Arnab, Lahoud, Oscar B, Landau, Heather J, Landgren, Ola, Shaffer, Brian C., Smith, Eric L., Koehne, Guenther, Perales, Miguel-Angel, Giralt, Sergio A., Chung, David J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609585/
https://ncbi.nlm.nih.gov/pubmed/32712326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.07.016
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller